# Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

> **NCT00823745** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 7 (actual)

## Conditions studied

- HCV

## Interventions

- **DRUG:** [14C]-PF-00868554

## Key facts

- **NCT ID:** NCT00823745
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2009-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823745, "Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00823745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*